Biblioteca Hospital 12 de Octubre

Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis (Registro nro. 12435)

000 -CABECERA
Campo de control de longitud fija 03566na a2200217 4500
003 - IDENTIFICADOR DEL NÚMERO DE CONTROL
Campo de control PC12435
005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN
Campo de control 20180417112920.0
008 - CÓDIGOS DE INFORMACIÓN DE LONGITUD FIJA
Campo de control de longitud fija 130622s2011
040 ## - FUENTE DE LA CATALOGACIÓN
Centro transcriptor H12O
041 ## - CÓDIGO DE LENGUA
Código de lengua del texto/banda sonora o título independiente eng
100 ## - PUNTO DE ACCESO PRINCIPAL - NOMBRE DE PERSONA
9 (RLIN) 501
Nombre de persona Hawkins Carranza, Federico Gustavo
Término indicativo de función Endocrinología y Nutrición
100 ## - PUNTO DE ACCESO PRINCIPAL - NOMBRE DE PERSONA
Nombre de persona Martínez Díaz-Guerra, Guillermo
9 (RLIN) 760
Término indicativo de función Endocrinología y Nutrición
245 00 - MENCIÓN DE TÍTULO
Título Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis
Tipo de material [artículo]
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Nombre del editor distribuidor etc. Bone,
Fecha de publicación distribución etc. 2011.
300 ## - DESCRIPCIÓN FÍSICA
Extensión 48(5):972-978.
500 ## - NOTA GENERAL
Nota general Formato Vancouver:
Ma YL, Marín F, Stepan J, Ish-Shalom S, Möricke R, Hawkins F, et al. Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis. Bone. 2011;48(5):972-8.
504 ## - NOTA DE BIBLIOGRAFÍA; ETC.
Nota de bibliografía etc. Contiene 55 referencias, 3 tablas y 1 figura.
520 ## - NOTA DE SUMARIO; ETC.
Sumario etc. Resumen:
The periosteum contains osteogenic cells that regulate the outer shape of bone and contribute to determine its cortical thickness, size and position. We assessed the effects of subcutaneous injections of teriparatide (TPTD, 20 mu g/day) or oral strontium ranelate (SrR, 2 g/day) in postmenopausal women with osteoporosis on new bone formation activity at the periosteal and endosteal bone surfaces using dynamic histomorphometric measurements. Evaluable tetracycline-labeled transiliac crest bone biopsies were analyzed from 27 patients in the TPTD group, and 22 in the SrR group after six months of treatment. Measurements were conducted on the thicker and thinner cortices separately, and comparisons between the thicker, thinner and combined cortices were carried out. At the combined periosteal cortex, the mineralization surface as a percent of bone surface (MS/BS%) was greater for TPTD (mean +/- SE: 8.08 +/- 1.22%) than SrR (3.22 +/- 1.05%) (p < 0.005). The difference in mineral apposition rate (MAR) between TPTD (0.35 +/- 0.06 mu m/day) and SrR (0.14 +/- 0.06 mu m/day) was also significant (p < 0.05), while that of bone formation rate per bone surface (BFR/BS) between TPTD (0.014 +/- 0.004 mm(3)/mm(2)/year) and SrR (0.004 +/- 0.003 mm(3)/mm(2)/year) was not (p = 0.057). Statistically significant differences between the two treatments were also observed for MS/BS%, BFR/BS, MAR and the double-labeled perimeter in the periosteum of the thicker, but not thinner, iliac crest cortices. The comparison between the thicker and thinner cortices of both periosteal and endosteal surfaces showed statistically significant differences for MAR and the double-labeled perimeter for TPTD treated women. There were no statistically significant differences in any bone formation dynamic measurements between the two cortices in the SrR group. In conclusion, most of the bone formation and mineralization variables were significantly higher for TPTD- than SrR-treated women at both the periosteal and endosteal combined cortices. The response to TPTD for dynamic bone formation measurements in the periosteal surface was greater for the thicker than thinner cortex, but this difference was not significant in SrR treated patients. This may reflect a greater ability of TPTD to enhance responsiveness of bone to the mechanical loading environment These effects on bone formation may underlie the improvement in bone quality in patients with osteoporosis treated with TPTD. (C) 2011 Elsevier Inc. All rights reserved.
856 ## - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS
Identificador Uniforme del Recurso (URI) http://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc12435.pdf
Acceso Solicitar documento
942 ## - ENTRADA PARA ELEMENTOS AGREGADOS (KOHA)
Fuente de clasificación o esquema de ordenación en estanterías
Koha [por defecto] tipo de item Artículo
Suprimido en OPAC Público
Existencias
Suprimido Estado de pérdida Fuente de clasificación o esquema de ordenación en estanterías Estropeado No para préstamo Localización permanente Localización actual Fecha de adquisición Signatura completa Fecha última consulta Fecha del precio de reemplazo Tipo de item de Koha
          Hospital Universitario 12 de Octubre Hospital Universitario 12 de Octubre 2014-07-30 PC12435 2014-07-30 2014-07-30 Artículo

Con tecnología Koha